FY26 Half Year Results Media Release
Filed with ASX · · 6 pages · English
• Revenue and other income of $393.5m, up 55.6% • Operating EBITDA of $81.1m, up 75.6% • Operating EBITDA margin of 20.6%, up 2.3% from 18.3% • Operating NPAT of $22.3m, up 154.6% • Statutory NPAT of $9.0m, includes $13.3m principally relating to transaction and integration costs, restructuring costs, remeasurement of contingent consideration liabilities, and share based expenses, net of tax • Ope
Integral Diagnostics Ltd on 6ix
In the deck
Story so far
Earlier from Integral Diagnostics
- FY26 Half Year Results App4D and Interim Report
- Appointment of Managing Director and Chief Executive Officer
- AGM - CEO's Address and Presentation
- FY25 Investor Presentation
- FY25 Results Announcement
Later from Integral Diagnostics
- FY26 Half Year Results Investor Presentation
- Commencement Date for New MD & CEO
- Start for New Managing Director and Chief Executive Officer
- Preliminary FY26 Results and Appointment of New CFO
- FY26 Annual Report
Follow Integral Diagnostics into a list and get an email when it puts out news.
Follow Integral Diagnostics